{"id":9271,"date":"2021-01-13T13:58:22","date_gmt":"2021-01-13T18:58:22","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/"},"modified":"2021-01-13T13:58:22","modified_gmt":"2021-01-13T18:58:22","slug":"nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/","title":{"rendered":"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments"},"content":{"rendered":"<p><strong>Ottawa, le 13\u00a0janvier\u00a02021\u00a0\u2013 <\/strong>La croissance des maladies chroniques et la hausse des demandes de remboursement de m\u00e9dicaments sont deux des principaux facteurs qui font augmenter le co\u00fbt des r\u00e9gimes priv\u00e9s d\u2019assurance maladie, selon le rapport <a href=\"https:\/\/betteraccessbetterhealth.ca\/wp-content\/uploads\/2020\/12\/2020-Cost-Driver-report-EN.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2016 \u2013 2019 Analyse des g\u00e9n\u00e9rateurs de co\u00fbt des demandes de r\u00e8glement de m\u00e9dicaments des r\u00e9gimes d\u2019assurance priv\u00e9s<\/a> (en anglais, \u00e0 l\u2019exception du <a href=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2021\/01\/20200406-Cost-Driver-report-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">sommaire ex\u00e9cutif<\/a>) de M\u00e9dicaments novateurs Canada (MNC) publi\u00e9 aujourd\u2019hui. Le rapport pr\u00e9cise \u00e9galement que le co\u00fbt des demandes de remboursement de m\u00e9dicaments augmente d\u2019environ 5 % par an, ce qui repr\u00e9sente moins de la moiti\u00e9 du 11 % pr\u00e9vu par les assureurs.<\/p>\n<p>Le rapport indique que les importantes augmentations de co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance maladie au pays r\u00e9sultent d\u2019une utilisation accrue, elle-m\u00eame caus\u00e9e par la croissance des maladies chroniques, comme le diab\u00e8te, qui n\u00e9cessitent davantage de m\u00e9dicaments. Compte tenu des r\u00e9percussions importantes de ces maladies sur les co\u00fbts et l\u2019augmentation des demandes de remboursement, sans oublier leurs co\u00fbts sociaux et \u00e9conomiques, les employeurs, les fournisseurs de r\u00e9gimes et les autres intervenants devraient travailler ensemble pour offrir aux participants des solutions qui les aideront \u00e0 pr\u00e9venir les maladies chroniques.<\/p>\n<p>Il est \u00e9galement n\u00e9cessaire d\u2019accro\u00eetre la collaboration entre les fabricants de m\u00e9dicaments, les assureurs, les conseillers et les promoteurs de r\u00e9gime d\u2019assurance m\u00e9dicaments\u00a0: ils doivent coop\u00e9rer pour comprendre et surmonter les difficult\u00e9s relatives \u00e0 l\u2019augmentation des maladies chroniques et \u00e0 leurs r\u00e9percussions sur la sant\u00e9 de la population, ainsi que pour s\u2019assurer que les participants aux r\u00e9gimes ont acc\u00e8s aux services de sant\u00e9 dont ils ont besoin.<\/p>\n<p><strong>Faits saillants<\/strong><\/p>\n<ul>\n<li>De plus en plus d\u2019employ\u00e9s font des demandes de remboursement. Selon le rapport, le co\u00fbt des demandes pour les r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments a augment\u00e9 selon un taux de croissance annuel compos\u00e9 de 5,3\u00a0% entre 2016 et 2019. Plus de la moiti\u00e9 de cette croissance est due \u00e0 une utilisation accrue, plut\u00f4t qu\u2019\u00e0 une augmentation du montant des demandes, ce qui sugg\u00e8re que le prix des m\u00e9dicaments n\u2019est pas le principal facteur influen\u00e7ant la croissance globale des co\u00fbts.<\/li>\n<li>Les maladies chroniques sont un important facteur de co\u00fbt pour les r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments. Elles repr\u00e9sentent 68\u00a0% des demandes et sont responsables de 79\u00a0% de leur augmentation.<\/li>\n<li>L\u2019augmentation des co\u00fbts des demandes effectu\u00e9es aupr\u00e8s des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments au Canada peut \u00eatre attribu\u00e9e \u00e0 trois principaux facteurs\u00a0: l\u2019augmentation du nombre de prestataires, l\u2019augmentation du nombre de demandes effectu\u00e9es par les prestataires et l\u2019augmentation des co\u00fbts de chaque demande. Ce dernier peut \u00eatre caus\u00e9 par l\u2019adoption de nouveaux m\u00e9dicaments innovants ou par certains facteurs comme les frais de distribution et la fr\u00e9quence de d\u00e9livrance.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/betteraccessbetterhealth.ca\/wp-content\/uploads\/2020\/12\/2020-Cost-Driver-report-EN.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Lire le rapport complet<\/a> (en anglais, \u00e0 l\u2019exception du <a href=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2021\/01\/20200406-Cost-Driver-report-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">sommaire ex\u00e9cutif<\/a>).<\/p>\n<p><strong>Citation<\/strong><\/p>\n<blockquote><p>Nous esp\u00e9rons que ce rapport permettra aux conseillers et aux promoteurs de r\u00e9gime d\u2019assurance m\u00e9dicaments, petits ou grands, de mieux comprendre les facteurs de co\u00fbts qui influencent ces r\u00e9gimes. Forts de ces connaissances, ils seront en mesure de g\u00e9rer plus efficacement les r\u00e9gimes et de n\u00e9gocier des primes et des cotisations r\u00e9alistes, ce qui leur permettra de continuer \u00e0 offrir ces importants avantages \u00e0 leurs employ\u00e9s.<\/p>\n<p><em>Joe Farago, Directeur ex\u00e9cutif, Payeurs priv\u00e9s et investissements, MNC<\/em><\/p><\/blockquote>\n<h2>\u00c0 propos de M\u00e9dicaments novateurs Canada<\/h2>\n<p>M\u00e9dicaments novateurs Canada est la voix nationale de l\u2019industrie pharmaceutique innovatrice canadienne. Nous plaidons en faveur de politiques qui permettent la d\u00e9couverte, le d\u00e9veloppement et la commercialisation de m\u00e9dicaments et vaccins novateurs qui am\u00e9liorent la vie de tous les Canadiens. Nous appuyons l\u2019engagement de nos membres d\u2019\u00eatre des partenaires pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien.<\/p>\n<p style=\"text-align: center;\">\u2013 30 \u2013<\/p>\n<h2>Pour de plus amples renseignements\u00a0:<\/h2>\n<p>Sarah Dion-Marquis<br \/>\nDirectrice, M\u00e9dias et relations publiques<br \/>\nT\u00e9l\u00e9phone\u00a0: (613)\u00a0769-6510<br \/>\nCourriel\u00a0:\u00a0<a href=\"mailto:sdmarquis@imc-mnc.ca\">sdmarquis@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La croissance des maladies chroniques [&#8230;]<\/p>\n","protected":false},"featured_media":19795,"template":"","topic":[],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-9271","news","type-news","status-publish","has-post-thumbnail","hentry","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"La croissance des maladies chroniques [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/\",\"name\":\"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/New-IMC-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans-scaled.jpg\",\"datePublished\":\"2021-01-13T18:58:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/New-IMC-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/New-IMC-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans-scaled.jpg\",\"width\":1980,\"height\":1320},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/all-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/","og_locale":"fr_FR","og_type":"article","og_title":"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments - Innovative Medicines Canada","og_description":"La croissance des maladies chroniques [...]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/","og_site_name":"Innovative Medicines Canada","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/","name":"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2021\/01\/New-IMC-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans-scaled.jpg","datePublished":"2021-01-13T18:58:22+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2021\/01\/New-IMC-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans-scaled.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2021\/01\/New-IMC-report-shows-impact-of-chronic-disease-and-increased-claims-on-private-drug-plans-scaled.jpg","width":1980,"height":1320},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/nouveau-rapport-de-mnc-sur-les-couts-des-regimes-prives-dassurance-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/"},{"@type":"ListItem","position":3,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/all-news\/"},{"@type":"ListItem","position":4,"name":"Nouveau rapport de MNC sur les co\u00fbts des r\u00e9gimes priv\u00e9s d\u2019assurance m\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/9271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/19795"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=9271"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=9271"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=9271"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=9271"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=9271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}